What You Should Know:
- As COVID-19 spreads, DreaMed Diabetes unveils virtual diabetes clinic software to treat people with type 1 diabetes remotely.
- The virtual clinic utilizes Dreamed Diabetes’ AI-powered solution, to improve the insulin management treatment by analyzing the patient’s insulin and glucose data in the platform's algorithm and to remotely advise doctors on treatment.
- According to the CDC people with chronic medical conditions, including diabetes, have a higher risk
Read More
type 1 diabetes
Livongo, VSP Vision Care Partner to Improve Eye Care for People Living with Diabetes
- Livongo announced a partnership with VSP Vision Care to offer mutual Members resources and insights to manage chronic conditions and vision care on one platform. - People with diabetes and prediabetes have an increased risk of vision complications and vision loss and by offering them resources to better manage their eye health on the Livongo platform, we can effectively close gaps in care. Livongo Health, Inc., an Applied Health Signals company empowering people with chronic conditions to live
Read More
Livongo Inks $50M Diabetes Contract Through Federal Employees Health Benefits Program (FEHBP)
- Livongo has been awarded a contract to provide the Livongo for Diabetes solution to eligible members covered by the Federal Employees Health Benefits Program (FEHBP ) under one health plan.- The contract is Livongo’s biggest contract in company history and will account for $20-25M in revenue in 2020 and $30-35M in revenue for 2021, representing a total of $50-60M including both years.- The announcement reflects Livongo’s overall market traction and how they are expanding from working primarily
Read More
Progentec Diagnostics Merges with Karate Health to Expand Autoimmune Disease Management Platforms
Karate Health merges with Progentec to pursue comprehensive disease management solutions for lupus and multiple sclerosis (MS) that combine laboratory testing with digital technologies. Progentec Diagnostics, Inc. and Karate Health, Inc. announced that they have merged, offering laboratory testing and digital technologies for the diagnosis and management of lupus (SLE), multiple sclerosis (MS), and other autoimmune diseases. The merger is a substantive step towards the Progentec mission of
Read More
Glooko Appoints Dr. Mark Clements as Chief Medical Officer
Glooko, a provider of diabetes data management solutions, today announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory board since it was formed in 2015 to provide expertise to the organization in the areas of clinical studies and diabetes analytics.
Dr. Clements comes to Glooko from the University of Missouri-Kansas City School of Medicine, where he is Associate
Read More
NHS England Publishes New Guidelines on Flash Glucose Monitors for Type 1 Diabetes Patients
NHS England recently published clinical guidance for flash glucose monitors that outlines funding arrangements for patients with type 1 diabetes and the qualifying criteria to support local health groups. According to NHS England, an estimated 260,000 in England suffer from type 1 diabetes.Starting in April, the NHS will provide the technology for one in five of those with type 1 diabetes in England. Those who qualify include:- People with type 1 diabetes who need intensive monitoring (more than
Read More
New Saliva Glucose Biosensor Could Eliminate Finger Pricks for Diabetes
New non-invasive, saliva-based glucose test measures glucose in saliva rather than blood could eliminate finger pricks for diabetes management.The iQ Group Global, a Sydney, Australia-based consortium of life science and financial services companies has unveiled the Saliva Glucose Biosensor, a non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva rather than blood. The saliva-based glucose test could eliminate painful finger pricks for diabetes
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
New Study Reveals Personalization is Key to Diabetes Management
New study led by Livongo demonstrates that personalization is key to diabetes management and short periods of intensive coaching when people get stuck on their way to their glucose and weight goals can be helpful. A new study reveals that use of Livongo for Diabetes significantly improves the health of people with type 2 diabetes (T2D), according to recent findings reported in the Journal of Diabetes Research. Researchers also found pairing participation in Livongo for Diabetes with lifestyle
Read More
AHRQ Report: Mobile Apps Have Little Clinical Evidence of Improving Diabetes for Patients
A new report by the Agency for Healthcare Research and Quality (AHRQ) on mobile phone applications for diabetes patients reveals that out of hundreds of commercially available apps, only 11 had been researched, and of these, only five were associated with clinically significant improvements in levels of blood sugar control as measured by hemoglobin A1c (HbA1c) tests.Report OverviewAHRQ-funded researchers sought to understand the effectiveness of roughly 280 apps that may be used to support
Read More
